L-Leucine
L-Leucine is a pharmaceutical drug with 8 clinical trials. Currently 2 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
2
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Plasma Trimethylamine N-oxide Elevation Induced by L-carnitine Supplementation and Insulin Resistance
Leucine in Midlife Depression
Effects of Intragastric Quinine, Alone or Combined With L-leucine, on Postprandial Glycaemic Control
Rapid Antidepressant Effects of Leucine
Carnitine Supplementation and Bone Mineral Density
Clinical Trials (8)
Plasma Trimethylamine N-oxide Elevation Induced by L-carnitine Supplementation and Insulin Resistance
Leucine in Midlife Depression
Effects of Intragastric Quinine, Alone or Combined With L-leucine, on Postprandial Glycaemic Control
Rapid Antidepressant Effects of Leucine
Carnitine Supplementation and Bone Mineral Density
The Effect of Leucine on Carnitine Transport to Skeletal Muscle
L-leucine in Diamond Blackfan Anemia Patients
Study to Assess the Effect of Leucine Along With Resistance Exercise on Muscle Strength and Quality of Life in Elders
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8